Kenneth Londoner - May 25, 2021 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Stock symbol
BSGM
Transactions as of
May 25, 2021
Transactions value $
$16,390
Form type
4/A - Amendment
Date filed
9/3/2021, 04:45 PM
Date Of Original Report
May 26, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Purchase $3.32K +1K +0.06% $3.32* 1.65M May 25, 2021 Direct F1
transaction BSGM Common Stock Purchase $3.3K +1K +0.06% $3.30* 1.65M May 25, 2021 Direct F1
transaction BSGM Common Stock Purchase $3.31K +1K +0.06% $3.31* 1.65M May 25, 2021 Direct F1
transaction BSGM Common Stock Purchase $3.23K +1K +0.06% $3.23* 1.65M May 25, 2021 Direct F1
transaction BSGM Common Stock Purchase $3.23K +1K +0.06% $3.23* 1.65M May 25, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purpose of this Amendment is to correct the Transaction Code in column 3 of Table I, which inadvertently used Transaction Code "A" instead of "P".